These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10700428)

  • 1. Blockade of endogenous interleukin 12 results in suppression of murine streptococcal cell wall arthritis by enhancement of interleukin 10 and interleukin 1Ra.
    Joosten LA; Helsen MM; van Den Berg WB
    Ann Rheum Dis; 2000 Mar; 59(3):196-205. PubMed ID: 10700428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis.
    Joosten LA; van De Loo FA; Lubberts E; Helsen MM; Netea MG; van Der Meer JW; Dinarello CA; van Den Berg WB
    J Immunol; 2000 Dec; 165(11):6553-8. PubMed ID: 11086098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis.
    Kuiper S; Joosten LA; Bendele AM; Edwards CK; Arntz OJ; Helsen MM; Van de Loo FA; Van den Berg WB
    Cytokine; 1998 Sep; 10(9):690-702. PubMed ID: 9770330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis.
    Joosten LA; Heuvelmans-Jacobs M; Lubberts E; van de Loo FA; Bakker AC; Helsen MM; Richards CD; van den Berg WB
    Arthritis Rheum; 2002 May; 46(5):1379-89. PubMed ID: 12115246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice.
    Plater-Zyberk C; Joosten LA; Helsen MM; Hepp J; Baeuerle PA; van den Berg WB
    Ann Rheum Dis; 2007 Apr; 66(4):452-7. PubMed ID: 17020908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.
    Lubberts E; Joosten LA; Helsen MM; van den Berg WB
    Cytokine; 1998 May; 10(5):361-9. PubMed ID: 9619374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
    Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis.
    Chen W; Jin W; Cook M; Weiner HL; Wahl SM
    J Immunol; 1998 Dec; 161(11):6297-304. PubMed ID: 9834119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-regulated local IL-10 gene therapy diminishes synovitis and cartilage proteoglycan depletion in experimental arthritis.
    Vermeij EA; Broeren MG; Bennink MB; Arntz OJ; Gjertsson I; van Lent PL; van den Berg WB; Koenders MI; van de Loo FA
    Ann Rheum Dis; 2015 Nov; 74(11):2084-91. PubMed ID: 25028707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4 induced FcgammaR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: Toll-like receptor 4 largely regulates FcgammaR expression by interleukin 10.
    van Lent PL; Blom AB; Grevers L; Sloetjes A; van den Berg WB
    Ann Rheum Dis; 2007 Mar; 66(3):334-40. PubMed ID: 17068066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis.
    Marijnissen RJ; Roeleveld DM; Young D; Nickerson-Nutter C; Abdollahi-Roodsaz S; Garcia de Aquino S; van de Loo FA; van Spriel AB; Boots AM; van den Berg WB; Koenders MI
    Arthritis Rheumatol; 2014 Apr; 66(4):886-95. PubMed ID: 24757141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2.
    Heinhuis B; Koenders MI; van de Loo FA; van Lent PL; Kim SH; Dinarello CA; Joosten LA; van den Berg WB
    Ann Rheum Dis; 2010 Oct; 69(10):1866-72. PubMed ID: 20472585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of parathyroid hormone-related protein prevents joint destruction and granuloma formation in streptococcal cell wall-induced arthritis.
    Funk JL; Chen J; Downey KJ; Davee SM; Stafford G
    Arthritis Rheum; 2003 Jun; 48(6):1721-31. PubMed ID: 12794841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
    Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB
    Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.
    Joosten LA; Lubberts E; Durez P; Helsen MM; Jacobs MJ; Goldman M; van den Berg WB
    Arthritis Rheum; 1997 Feb; 40(2):249-60. PubMed ID: 9041936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts.
    Palmer G; Mezin F; Juge-Aubry CE; Plater-Zyberk C; Gabay C; Guerne PA
    Ann Rheum Dis; 2004 Jan; 63(1):43-9. PubMed ID: 14672890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.